Cargando…

Metabolic Targeting of Cancer Stem Cells

Most human tumors possess a high heterogeneity resulting from both clonal evolution and cell differentiation program. The process of cell differentiation is initiated from a population of cancer stem cells (CSCs), which are enriched in tumor‐regenerating and tumor‐propagating activities and responsi...

Descripción completa

Detalles Bibliográficos
Autores principales: Mukha, Anna, Dubrovska, Anna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7783393/
https://www.ncbi.nlm.nih.gov/pubmed/33415069
http://dx.doi.org/10.3389/fonc.2020.537930
_version_ 1783632103984857088
author Mukha, Anna
Dubrovska, Anna
author_facet Mukha, Anna
Dubrovska, Anna
author_sort Mukha, Anna
collection PubMed
description Most human tumors possess a high heterogeneity resulting from both clonal evolution and cell differentiation program. The process of cell differentiation is initiated from a population of cancer stem cells (CSCs), which are enriched in tumor‐regenerating and tumor‐propagating activities and responsible for tumor maintenance and regrowth after treatment. Intrinsic resistance to conventional therapies, as well as a high degree of phenotypic plasticity, makes CSCs hard-to-target tumor cell population. Reprogramming of CSC metabolic pathways plays an essential role in tumor progression and metastatic spread. Many of these pathways confer cell adaptation to the microenvironmental stresses, including a shortage of nutrients and anti-cancer therapies. A better understanding of CSC metabolic dependences as well as metabolic communication between CSCs and the tumor microenvironment are of utmost importance for efficient cancer treatment. In this mini-review, we discuss the general characteristics of CSC metabolism and potential metabolic targeting of CSC populations as a potent strategy to enhance the efficacy of conventional treatment approaches.
format Online
Article
Text
id pubmed-7783393
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-77833932021-01-06 Metabolic Targeting of Cancer Stem Cells Mukha, Anna Dubrovska, Anna Front Oncol Oncology Most human tumors possess a high heterogeneity resulting from both clonal evolution and cell differentiation program. The process of cell differentiation is initiated from a population of cancer stem cells (CSCs), which are enriched in tumor‐regenerating and tumor‐propagating activities and responsible for tumor maintenance and regrowth after treatment. Intrinsic resistance to conventional therapies, as well as a high degree of phenotypic plasticity, makes CSCs hard-to-target tumor cell population. Reprogramming of CSC metabolic pathways plays an essential role in tumor progression and metastatic spread. Many of these pathways confer cell adaptation to the microenvironmental stresses, including a shortage of nutrients and anti-cancer therapies. A better understanding of CSC metabolic dependences as well as metabolic communication between CSCs and the tumor microenvironment are of utmost importance for efficient cancer treatment. In this mini-review, we discuss the general characteristics of CSC metabolism and potential metabolic targeting of CSC populations as a potent strategy to enhance the efficacy of conventional treatment approaches. Frontiers Media S.A. 2020-12-22 /pmc/articles/PMC7783393/ /pubmed/33415069 http://dx.doi.org/10.3389/fonc.2020.537930 Text en Copyright © 2020 Mukha and Dubrovska http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Mukha, Anna
Dubrovska, Anna
Metabolic Targeting of Cancer Stem Cells
title Metabolic Targeting of Cancer Stem Cells
title_full Metabolic Targeting of Cancer Stem Cells
title_fullStr Metabolic Targeting of Cancer Stem Cells
title_full_unstemmed Metabolic Targeting of Cancer Stem Cells
title_short Metabolic Targeting of Cancer Stem Cells
title_sort metabolic targeting of cancer stem cells
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7783393/
https://www.ncbi.nlm.nih.gov/pubmed/33415069
http://dx.doi.org/10.3389/fonc.2020.537930
work_keys_str_mv AT mukhaanna metabolictargetingofcancerstemcells
AT dubrovskaanna metabolictargetingofcancerstemcells